BackOcean Biomedical Overview

Ocean Biomedical Net Income

Track Ocean Biomedical's net income ($-25M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$8.24M
163.39% YoY

As of Mar 2025

Annual Net Income (TTM)

-$24.54M
20.77% YoY

Trailing 12 months ending Mar 2025

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Ocean Biomedical (OCEA) FAQ

Ocean Biomedical (OCEA) currently reports a net income of $-25M as of March 2025. That compares with $-31M in the prior-year period — up 20.8% year over year. That is below the sector sector average of $87M. Use the charts on this page to explore Ocean Biomedical's net income history and peer comparisons.

Ocean Biomedical's net income increased from $-31M to $-25M — a 20.8% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ocean Biomedical's net income of $-25M is lower than the its sector sector average of $87M. That is roughly 128.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Ocean Biomedical reported $-25M in net income as of March 2025. That compares with $-31M in the prior-year period — up 20.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-25M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $87M. From there, open related valuation or income-statement pages for Ocean Biomedical, and consider following OCEA for alerts when major investors trade the stock.